These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 10590373)

  • 1. Correlation of CD44S expression in renal clear cell carcinomas with subsequent tumor progression or recurrence.
    Gilcrease MZ; Guzman-Paz M; Niehans G; Cherwitz D; McCarthy JB; Albores-Saavedra J
    Cancer; 1999 Dec; 86(11):2320-6. PubMed ID: 10590373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of CD44 isoforms in human renal cell carcinomas.
    Heider KH; Ratschek M; Zatloukal K; Adolf GR
    Virchows Arch; 1996 Jul; 428(4-5):267-73. PubMed ID: 8764936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis.
    Ropponen KM; Eskelinen MJ; Lipponen PK; Alhava E; Kosma VM
    Scand J Gastroenterol; 1998 Mar; 33(3):301-9. PubMed ID: 9548625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CD44 protein in renal cell carcinomas: association with p53 expression.
    Zolota V; Tsamandas AC; Melachrinou M; Batistatou A; Scopa C
    Urol Oncol; 2002; 7(1):13-7. PubMed ID: 12474536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression of CD44s in renal cell carcinoma lacks independent prognostic significance.
    Costa WH; Rocha RM; Cunha IW; Guimaraes GC; Zequi Sde C
    Int Braz J Urol; 2012; 38(4):456-65. PubMed ID: 22951174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44 loss in gastric stromal tumors as a prognostic marker.
    Montgomery E; Abraham SC; Fisher C; Deasel MR; Amr SS; Sheikh SS; House M; Lilliemoe K; Choti M; Brock M; Ephron DT; Zahuruk M; Chadburn A
    Am J Surg Pathol; 2004 Feb; 28(2):168-77. PubMed ID: 15043305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent CD44s and STAT3 expression in human clear cell renal cellular carcinoma and its impact on survival.
    Qin J; Yang B; Xu BQ; Smithc A; Xu L; Yuan JL; Li L
    Int J Clin Exp Pathol; 2014; 7(6):3235-44. PubMed ID: 25031744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of osteopontin and CD44 molecule in papillary renal cell tumors.
    Matusan K; Dordevic G; Mozetic V; Lucin K
    Pathol Oncol Res; 2005; 11(2):108-13. PubMed ID: 15999156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 variant overexpression in gallbladder carcinoma associated with tumor dedifferentiation.
    Yanagisawa N; Mikami T; Mitomi H; Saegusa M; Koike M; Okayasu I
    Cancer; 2001 Jan; 91(2):408-16. PubMed ID: 11180088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44 splice variant expression in clear cell carcinoma of the ovary.
    Rodríguez-Rodríguez L; Sancho-Torres I; Leakey P; Gibbon DG; Comerci JT; Ludlow JW; Mesonero C
    Gynecol Oncol; 1998 Nov; 71(2):223-9. PubMed ID: 9826464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CD44 isoforms in infiltrating lobular carcinoma of the breast.
    Berner HS; Nesland JM
    Breast Cancer Res Treat; 2001 Jan; 65(1):23-9. PubMed ID: 11245336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the CD44 cell adhesion molecule in urinary bladder transitional cell carcinoma.
    Ross JS; del Rosario AD; Bui HX; Kallakury BV; Okby NT; Figge J
    Mod Pathol; 1996 Aug; 9(8):854-60. PubMed ID: 8871928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
    Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
    Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas.
    Tran TA; Kallakury BV; Sheehan CE; Ross JS
    Hum Pathol; 1997 Jul; 28(7):809-14. PubMed ID: 9224749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas.
    Berner HS; Suo Z; Risberg B; Villman K; Karlsson MG; Nesland JM
    Histopathology; 2003 Jun; 42(6):546-54. PubMed ID: 12786890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of very late activation integrin and CD44 expression with extrarenal invasion and metastasis of renal cell carcinomas.
    Gilcrease MZ; Truong L; Brown RW
    Hum Pathol; 1996 Dec; 27(12):1355-60. PubMed ID: 8958311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44s and CD44v6 expression in localized T1-T2 conventional renal cell carcinomas.
    Daniel L; Lechevallier E; Giorgi R; Lindner V; De Fromont M; Vieillefond A; Coulange C; Figarella-Branger D
    J Pathol; 2001 Mar; 193(3):345-9. PubMed ID: 11241414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CD44 and P53 in renal cell carcinoma: association with tumor subtypes.
    Noroozinia F; Fahmideh AN; Yekta Z; Rouhrazi H; Rasmi Y
    Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):79-84. PubMed ID: 24434386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of extensive necrosis in renal cell carcinoma.
    Collins J; Epstein JI
    Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of CD44 molecule in renal cell carcinoma.
    Lucin K; Matusan K; Dordević G; Stipić D
    Croat Med J; 2004 Dec; 45(6):703-8. PubMed ID: 15578803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.